Profile
David Borah is Chief Financial Officer at Desert Control AS since 2026.
Former roles include Director & Portfolio Manager at The Boston Company Asset Management LLC from 2015 to 2016;.
Analyst at Wellington Management Co. LLP from 1998 to 2000; Partner & Associate Portfolio Manager at Century Capital Management LLC from 2009 to 2013; Research Analyst at Liberty Ridge Capital, Inc. from 2000 to 2003; Vice President & Equity Research Analyst at GW&K Investment Management LLC from 2019 to 2021; SVP-Investor Relations & Corporate Strategy at Geron Corp.
in 2025; Partner & Equity Analyst at Monarch Partners Asset Management LLC from 2016 to 2019; VP-Capital Markets & Investor Relations at Bicycle Therapeutics Plc from 2021 to 2023; Investor Contact at Mural Oncology Plc from 2023 to 2024; and SVP-Investor Relations & Corporate Communications at PepGen Inc. from 2024 to 2025.
Education includes an undergraduate degree from Brown University in 1992 and an MBA from Cornell University in 1996.
David Borah active positions
| Companies | Position | Start |
|---|---|---|
| DESERT CONTROL | Director of Finance/CFO | 2026-02-02 |
Former positions of David Borah
| Companies | Position | End |
|---|---|---|
| GERON CORPORATION | Investor Relations Contact | 2025-09-30 |
| PEPGEN INC. | Investor Relations Contact | 2025-03-31 |
| BICYCLE THERAPEUTICS PLC | Investor Relations Contact | 2023-06-30 |
GW&K Investment Management LLC
GW&K Investment Management LLC Investment ManagersFinance GW&K is a research-oriented adviser that primarily employs fundamental analysis for the evaluation of investment opportunities and the construction of investment portfolios. The firm specializes in Municipal Bond, Taxable Bond, Equity and Multi-Asset strategies. | Analyst-Equity | 2021-03-31 |
Training of David Borah
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
The Boston Company Asset Management LLC
The Boston Company Asset Management LLC Investment ManagersFinance The Boston Company Asset Management (TBCAM) offers both traditional and alternative equity investment products that encompass a variety of US, non-US and global strategies. The firm provides investment advice for the following types of strategies: US domestic equity, balanced, non-US equity, emerging markets equity and long/short equity. Portfolios generally are composed of individual securities. TBCAM seeks consistent delivery of alpha across a broad range of investment strategies. They are committed to a value-oriented, research-driven and risk-aware investment approach. TBCAM seeks to identify attractive stocks through rigorous quantitative and fundamental analyses blended with analysis of current business momentum and places controls on sector selection and, if applicable, country selection. Short sales and similar strategies are considered part of their overall investment strategy; however, they are not used across the account base in the management of account assets. The firm may use these strategies for certain accounts consistent with the client's guidelines, objectives, and restrictions. | Finance |
Wellington Management Co. LLP
Wellington Management Co. LLP Investment ManagersFinance WMC relies on their extensive independent research and includes portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has several different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macro-analysts, quantitative analysts and technical analysts. | Finance |
Century Capital Management LLC
Century Capital Management LLC Investment ManagersFinance Century Capital Management mainly invests in the common stocks of US small- and mid-cap companies. The firm also serves as the advisor to one mutual fund that invests in US companies with mid-to-large market-caps. Century’s primary method of analysis is fundamental, bottom-up research. They analyze a company’s competitive advantage, potential for growth in revenue and earnings, return on equity, quality of management, and the ability of the company’s capital structure to sustain future growth. Quantitative tools are used to augment fundamental research, and each prospective holding is subject to a rigorous intrinsic valuation analysis. The Small Cap Growth strategy and Century Small Cap Select Fund invest primarily in the common stocks of US companies with small market-caps typically not exceeding that of the largest company in the Russell 2000 index over the prior 12 months that have a growth orientation. The Small-Mid Cap Growth strategy and Century Growth Opportunities Fund invest primarily in the common stocks of small and medium-sized US companies with market-caps of $800 million to $6 billion selected for their growth potential. The Small Cap Value strategy invests primarily in the common stocks of companies with small market-caps that have a relative value orientation. The strategy invests in companies across all sectors of the economy and may include investments in foreign securities. Century Shares Trust invests primarily in the common stocks of US companies. The fund typically invests in large and medium sized companies, but may invest in any company without regard to market-cap. The fund invests in companies across all sectors of the economy, but may favor companies in particular sectors or industries at different times. The Small-Mid Cap strategy invests primarily in the common stocks of small and medium-sized US companies with market-caps of $500 million to $10 billion selected for their growth potential. | Finance |
Liberty Ridge Capital, Inc.
Liberty Ridge Capital, Inc. Investment ManagersFinance Liberty Ridge focuses on domestic equities. Liberty Ridge Capital believes it adds the greatest value over all market cycles by consistently applying a time-tested, bottom-up stock selection process that combines the use of rigorous fundamental research with quantitative techniques. Liberty Ridge Capital seeks to select securities that offer the most attractive trade-off between valuation, near-term dynamics and long-term growth. They believe that superior investment results can be achieved by investing in companies that possess an attractive valuation relative to the broad market and peer group, display positive near-term business prospects and exhibit healthy long-term earnings growth potential. LibertyRidge employs a process that defines a manageable universe of stocks by utilizing proprietary quantitative screens to narrow their focus. Fundamental research further narrows the team's top investment candidates and then a portfolio is constructed based on process and account parameters. In seeking to identify attractive investment opportunities for the Focused, Large Cap, Mid-Cap and Small Cap Funds and the blend portion of the Strategic Small Company Fund, Liberty Ridge first creates a universe of companies whose current share price seems lower than their current or future worth. They consider factors like a company's earnings power vs. its current stock price, dividend income potential, its price-to-earnings ratio vs. similar companies, competitive advantages, like brand or trade name or market niche, management team, and current and future business prospects. Lastly, using their own fundamental research and a bottom-up approach to investing, Liberty Ridge identifies those companies which are currently out of market favor but have the potential to achieve significant appreciation as the marketplace recognizes their fundamental value. | Finance |
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
GW&K Investment Management LLC
GW&K Investment Management LLC Investment ManagersFinance GW&K is a research-oriented adviser that primarily employs fundamental analysis for the evaluation of investment opportunities and the construction of investment portfolios. The firm specializes in Municipal Bond, Taxable Bond, Equity and Multi-Asset strategies. | Finance |
Brown University
Brown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bicycle Therapeutics Plc
Bicycle Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops molecules and oncology medicines | Health Technology |
Monarch Partners Asset Management LLC
Monarch Partners Asset Management LLC Investment ManagersFinance Monarch Partners utilizes a fundamental value investing approach to make long-only investments in Small-Cap Value Equity, SMID-Cap Value Equity and Micro-Cap Value strategies. They seek to identify undervalued companies that possess catalysts with the potential to enhance shareholder value, while avoiding value traps. The firm employs a proprietary bottom-up research process that is comprised of 90% fundamental research and 10% quantitative analysis. Monarch Partners attempts to mitigate risk through diversification, daily monitoring of portfolio exposures and the utilization of a strict sell discipline. | Finance |
PepGen Inc.
PepGen Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company which develops oligonucleotide therapeutics for treatment of severe neuromuscular and neurologic diseases | Health Technology |
Desert Control AS
Desert Control AS Chemicals: SpecialtyProcess Industries Manufactures clay liquid compounds to stop and reverse desertification and soil degradation | Process Industries |
- Stock Market
- Insiders
- David Borah
















